ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• No More Back And Forth: Building eCOAs Right The First Time

  Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.

• IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology

  Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.

• Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer

  This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.

• Rely On ePRO And EDC For Easier Cleaner Data

  What makes a clinical trials software provider a good fit? How do you make the decision to use a particular electronic data capture (EDC) system or electronic patient reported outcome (ePRO) solution? Learn how the answers are different for every sponsor and contract research organization (CRO).

• The Power Of A Collaboration Platform

  Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.

• The Impact Of Automation In The Monitoring And Reporting Process

  As clinical trial costs rise and ROIs decline, research teams are turning to automation to streamline monitoring and reporting processes without compromising data quality or regulatory compliance.

   

• Bridging The Knowledge Gap On Digital Clinical Measures: A Technology Partner's Perspective On The 'The Playbook'

  ActiGraph CEO, Jeremy Wyatt, shares his perspectives on The Playbook, the essential guide for remote patient monitoring in clinical research, clinical care and public health, compiled by the Digital Medicine Society (DiMe).

• The Advantages Of DCTs In Diabetes Research

  By harnessing technology platforms, discover how researchers can be better equipped to design studies for novel diabetes treatments that are safer, more efficient, and more effective.

• The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials

  Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.

• The Site's Guide To Recovering Clinical Technology Costs From Sponsors

  Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.